Abata Therapeutics

VP, Strategic Sourcing & Procurement

Remote

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Position Overview

  • Location Type:
  • Job Type:
  • Salary:

Apogee Therapeutics, Inc. is a well-funded, Nasdaq-listed biotechnology company founded in 2022. We are seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease, and other inflammatory and immunology indications with high unmet need. Our antibody programs aim to improve upon existing therapies by targeting well-established mechanisms of action and utilizing advanced antibody engineering. We are committed to reshaping the standard of care for inflammatory and immune diseases, driven by our belief that patients deserve the best possible treatment. Our company culture is built on C.O.R.E. values: Caring, Original, Resilient, and Egoless.

This newly created position will lead Apogee’s strategic sourcing and procurement efforts as the company grows. Reporting to the SVP of Finance, this role offers the opportunity to establish and build this critical function. A key aspect of this role is to build and manage long-term, mutually beneficial vendor relationships that drive value and support the company's mission. You will act as a strategic partner with functional business partners, particularly in clinical development, clinical operations, and manufacturing, to manage supplier selection, contract negotiation, and enforcement of terms.

Requirements

  • Lead strategic sourcing and procurement efforts.
  • Establish and grow the procurement function.
  • Build and manage long-term vendor relationships.
  • Act as a strategic partner with functional business units.
  • Manage supplier selection, contract development, and negotiation.
  • Enforce contract terms.

Responsibilities

  • Develop a sourcing strategy and conduct landscape analysis.
  • Engage with potential vendors and support business stakeholders in partner selection.
  • Identify, evaluate, and select qualified partners based on cost, quality, delivery, and innovation.
  • Develop and implement procurement strategies aligned with business goals.
  • Manage RFP/RFQ/RFI processes, reviewing materials with stakeholders and legal.
  • Develop criteria for and manage Apogee’s preferred vendor list.
  • Conduct spend analysis to understand spending patterns, supplier performance, and identify cost-saving opportunities.
  • Build and maintain strong relationships with key suppliers, fostering collaboration and ensuring quality and reliability.
  • Manage supplier performance and implement corrective actions when necessary.
  • Negotiate contracts to secure favorable terms and conditions with functional partners and legal.
  • Oversee procurement operations to ensure efficiency, cost-effectiveness, and compliance.
  • Ensure all procurement activities are conducted efficiently from requisition to payment.
  • Monitor and analyze procurement performance, tracking KPIs for continuous improvement.
  • Ensure procurement activities remain within functional budget constraints.
  • Ensure compliance with all relevant laws, regulations, and company policies.
  • Stay informed about industry trends and technologies in strategic sourcing and procurement, and share knowledge across the company.

About Apogee Therapeutics

Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally. Apogee Therapeutics, Inc. is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis, chronic obstructive pulmonary disease and other inflammatory and immunology indications with high unmet need. Our antibody programs are designed to potentially overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. We seek to reshape the current standard of care for inflammatory and immune diseases because we believe people living with these diseases deserve the best possible treatment, and we refuse to stop at “good enough.” We are a fast-paced company committed to building an exceptional company culture, founded on our C.O.R.E. values: Caring, Original, Resilient and Egoless.

Skills

Strategic Sourcing
Procurement
Vendor Relationship Management
Biotech Industry Knowledge
Supply Chain Strategy
Stakeholder Collaboration

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI